Alycia Garcia Campos
Family Medicine · Bakersfield, CANPI 1023269982
Payments from drug & device makers
Across 345 payments — averaging $15.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$732
- Nestle Healthcare Nutrition Inc.$609
- Pfizer$508
- Aimmune Therapeutics, Inc.$498
- Daiichi Sankyo Inc.$419
- AstraZeneca$398
- plus $2K from 31 others
What the payments were for
- Food & beverage$5,424100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 39 | $732 |
| Nestle Healthcare Nutrition Inc. | 71 | $609 |
| Pfizer | 26 | $508 |
| Aimmune Therapeutics, Inc. | 46 | $498 |
| Daiichi Sankyo Inc. | 22 | $419 |
| AstraZeneca | 21 | $398 |
| AbbVie(2 entities) | 19 | $348 |
| Lilly USA, LLC | 15 | $240 |
| Merck | 12 | $215 |
| Boehringer Ingelheim | 7 | $151 |
| Antares Pharma, Inc. | 6 | $123 |
| Otsuka America Pharmaceutical, Inc. | 6 | $105 |
| Bayer | 5 | $104 |
| Novartis | 4 | $95 |
| Astellas Pharma US Inc | 4 | $82 |
| Abbott | 3 | $74 |
| GSK | 4 | $69 |
| Amgen | 3 | $62 |
| Exact Sciences | 3 | $57 |
| Amarin Pharma, Inc. | 3 | $55 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $55 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $55 |
| Vertex | 2 | $50 |
| Idorsia Pharmaceuticals US Inc | 2 | $43 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| Johnson & Johnson | 2 | $32 |
| Corcept Therapeutics | 1 | $26 |
| Abiomed | 1 | $24 |
| Thea Pharma Inc. | 1 | $23 |
| Sage Therapeutics, LLC | 1 | $23 |
| Genentech USA, Inc. | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Lucid Diagnostics Inc. | 1 | $18 |
| Verity Pharmaceuticals Inc. | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Ironwood Pharmaceuticals, Inc | 1 | $13 |
| Phathom Pharmaceuticals, Inc. | 2 | $12 |
How this compares
$5,424 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 138 | $156,741 |
| OzempicSemaglutide | 92 | $123,698 |
| JanuviaSitagliptin Phosphate | 83 | $86,373 |
| FarxigaDapagliflozin Propanediol | 79 | $73,614 |
| EliquisApixaban | 43 | $31,465 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 17 | $19,234 |
| Xigduo XrDapaglifloz Propaned/Metformin | 20 | $17,137 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $12,797 |
| TrintellixVortioxetine Hydrobromide | 17 | $12,626 |
| TradjentaLinagliptin | 17 | $10,963 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 19 | $10,912 |
| LinzessLinaclotide | 15 | $10,528 |
| Tresiba Flextouch U-100Insulin Degludec | 22 | $8,619 |
| Atorvastatin Calcium | 925 | $7,164 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 50 | $6,952 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $151 | $167,704155 claims |
| Novo NordiskOzempic | $732 | $123,69892 claims |
| MerckJanuvia, Janumet Xr | $215 | $105,606100 claims |
| AstraZenecaFarxiga | $398 | $73,61479 claims |
| PfizerEliquis | $508 | $31,46543 claims |
| AbbVieLinzess, Synthroid | $348 | $15,60065 claims |
| GSKTrelegy Ellipta | $69 | $12,79722 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,533 family medicine providers in California.
Other family medicine in Bakersfield
- Amina HaggagNorthridge$112.8M
- Steven ReynoldsLong Beach$53M
- Rizwana MohseniLake Forest$26.7M
- Daniel JohnsonSan Diego$15.7M
- Stacey LayleSan Diego$14.8M
- Apinya VutikullirdCypress$14.3M
- Hanid AudishSpring Valley$13.6M
- Augusto FocilOxnard$12.6M
- Jack VuLong Beach$10.1M
- Suzanne FussellOxnard$8.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.